Site Map
Pages
Pipeline Programs
- Gemcitabine/nab-paclitaxel + LSTA1 (Phase 2b; China)
- Temozolomide with LSTA1 or placebo (Estonia/Latvia)
- LSTA1 + Hyperthermic intraperitoneal chemotherapy intraoperative intraperitoneal lavage (U.S.)
- Durvalumab, gemcitabine/nab-paclitaxel + LSTA1 (Australia)
- XOWNA® (LSTA16) (U.S.)
- HONEDRA® (LSTA12) (Japan)
- LSTA201 (U.S.)
- No-Option Refractory Disabling Angina